1. Hersh AL, Chambers HF, Maselli JH, Gonzales R (2008) National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 168:1585–1591
2. Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, Spalding J, Jiang J, Oster G (2009) Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis 15:1516–1518
3. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR (2007) Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004). Diagn Microbiol Infect Dis 57:7–13
4. European Centre for Disease Prevention and Control (2013) Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. ECDC, Stockholm
5. Itani KMF, Sorensen S, Stokes M, Shelbaya A, McKinnon P (2009) A regional comparison of resource utilization in patients with methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infections (CSSTI) treated with linezolid vs vancomycin. In: [Presentation O-1791] 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), San Francisco